461 related articles for article (PubMed ID: 12638470)
1. [Oral anticoagulation with vitamin K antagonists].
Alberio L
Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
[TBL] [Abstract][Full Text] [Related]
2. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
van Leeuwen Y; Rosendaal FR; van der Meer FJ
Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
[TBL] [Abstract][Full Text] [Related]
3. Phenprocoumon and acenocoumarol treatment in paediatric patients.
Spoor N; Smiers FJ; van der Meer FJ; Hutten BA; van Ommen CH
Thromb Haemost; 2012 Dec; 108(6):1238-41. PubMed ID: 23014894
[No Abstract] [Full Text] [Related]
4. [Anticoagulation by oral treatment with vitamin K antagonists].
Kemkes-Matthes B
Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171
[TBL] [Abstract][Full Text] [Related]
5. Main comedications associated with major bleeding during anticoagulant therapy with coumarins.
Penning-van Beest F; Erkens J; Petersen KU; Koelz HR; Herings R
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):439-44. PubMed ID: 15947920
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral antiplatelet agents on major bleeding in users of coumarins.
Schalekamp T; Klungel OH; Souverein PC; de Boer A
Thromb Haemost; 2008 Dec; 100(6):1076-83. PubMed ID: 19132233
[TBL] [Abstract][Full Text] [Related]
7. Optimization of vitamin K antagonist drug dose finding by replacement of the international normalized ratio by a bidirectional factor: validation of a new algorithm.
Beinema MJ; van der Meer FJ; Brouwers JR; Rosendaal FR
J Thromb Haemost; 2016 Mar; 14(3):479-84. PubMed ID: 26712475
[TBL] [Abstract][Full Text] [Related]
8. [How can we improve long-term anticoagulation?].
Beck EA
Schweiz Med Wochenschr; 1985 Oct; 115(43):1495-500. PubMed ID: 4081678
[TBL] [Abstract][Full Text] [Related]
9. Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effect on coagulation factor testing.
Walenga JM; Drenth AF; Mayuga M; Hoppensteadt DA; Prechel M; Harder S; Watanabe H; Osakabe M; Breddin HK
Clin Appl Thromb Hemost; 2008 Jul; 14(3):325-31. PubMed ID: 18586683
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort.
Maagdenberg H; Bierings MB; van Ommen CH; van der Meer FJM; Appel IM; Tamminga RYJ; de Boer A; Maitland-van der Zee AH
J Thromb Haemost; 2018 Jan; 16(1):116-124. PubMed ID: 29108090
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen Aalpha312 and Bbeta448 polymorphisms are not related to bleeding during oral vitamin K-antagonist treatment.
Garcia AA; van der Hoeven NV; Boellaard TN; van der Heijden JF; Groot AP; Reitsma PH
Thromb Haemost; 2007 Apr; 97(4):676-8. PubMed ID: 17393034
[No Abstract] [Full Text] [Related]
12. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
Angelo M; Stockner I; Wiedermann CJ
Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
[TBL] [Abstract][Full Text] [Related]
13. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
Rombouts EK; Rosendaal FR; van der Meer FJ
Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
[TBL] [Abstract][Full Text] [Related]
14. Reversal of vitamin K antagonists prior to urgent surgery.
Grobler C; Callum J; McCluskey SA
Can J Anaesth; 2010 May; 57(5):458-67. PubMed ID: 20077167
[TBL] [Abstract][Full Text] [Related]
15. Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants.
Visser LE; Penning-van Bees FJ; Kasbergen AA; De Smet PA; Vulto AG; Hofman A; Stricker BH
Thromb Haemost; 2002 Nov; 88(5):705-10. PubMed ID: 12428081
[TBL] [Abstract][Full Text] [Related]
16. [Perioperative care of patients taking vitamin K antagonists: register yourself!].
Steib A; Marret E; Albaladejo P; Piriou V
Ann Fr Anesth Reanim; 2010 Jan; 29(1):1-2. PubMed ID: 20159423
[No Abstract] [Full Text] [Related]
17. Differential cellular effects of old and new oral anticoagulants: consequences to the genesis and progression of atherosclerosis.
Schurgers LJ; Spronk HM
Thromb Haemost; 2014 Nov; 112(5):909-17. PubMed ID: 25298033
[TBL] [Abstract][Full Text] [Related]
18. Statin use decreases coagulation in users of vitamin K antagonists.
van Rein N; Biedermann JS; Bonafacio SM; Kruip MJ; van der Meer FJ; Lijfering WM
Eur J Clin Pharmacol; 2016 Dec; 72(12):1441-1447. PubMed ID: 27709253
[TBL] [Abstract][Full Text] [Related]
19. [Reversal of oral anticoagulation in intracranial hemorrhage].
Bösel J; Steiner T
Dtsch Med Wochenschr; 2010 Nov; 135(47):2366-9. PubMed ID: 21082529
[No Abstract] [Full Text] [Related]
20. Comparing thrombin generation in patients with hemophilia A and patients on vitamin K antagonists.
de Koning MLY; Fischer K; de Laat B; Huisman A; Ninivaggi M; Schutgens REG
J Thromb Haemost; 2017 May; 15(5):868-875. PubMed ID: 28296129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
